Tiziana Life Sciences Ltd (NASDAQ:TLSA) has unveiled new preclinical data suggesting that its investigational therapy, ...
· Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson’s disease, to be presented at the 2026 AD/PD™ Conference · Data evaluated safety, tolerability, ...
The study evaluated serum biomarkers of lipid peroxidation, systemic inflammation, and axonal integrity in 100 randomly selected patients with ALS and included 100 healthy controls to allow for a ...
Discusses Proposed Acquisition of Apellis and Strategic Growth Objectives March 31, 2026 8:30 AM EDTCompany ParticipantsTim Power - ...
A team of researchers from NYU Abu Dhabi and the University of Denver has identified a promising small molecule that could help slow or halt the progression of serious brain diseases such as Parkinson ...
Intramedullary tumors are rare among primary tumors of the central nervous system. They most often affect young adults, with no gender predominance. Spinal schwannomas account for approximately 30% of ...
Whole-body quantitative MRI, or qMRI, was found to detect subtle changes over time in the muscles of SMA adults, better than ...
Certain MS-driving immune cells express a protein marker called CD29, which helps these cells move into the brain and trigger inflammation.
The symptom profiles of different neurodegenerative diseases often overlap, and diagnosing age-related cognitive symptoms is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results